Tackling TKI resistance in AML: A commentary on "Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML." by Yamatani et al.
Translational oncology, cilt.19, ss.101394, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 19
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.tranon.2022.101394
- Dergi Adı: Translational oncology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals
- Sayfa Sayıları: ss.101394
- Anahtar Kelimeler: Acute myeloid leukemia, AML, FLT3, FLT3-ITD/D835, BCL2A1, Resistance
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet